![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zhao Hong-Ping Jiang Hong-Min Xiang Bing-Ren
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1437-1451
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Discontinued drugs in 2012: oncology drugs
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Discontinued drugs in 2007: cardiovascular drugs
By Xu-song Zhang Bing-ren Xiang
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Discontinued drugs in 2012: endocrine and metabolic
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. :